Abstract
Gastric electrical stimulation (GES) has proved to be an effective therapy for many patients with drug refractory gastroparesis. However, technological developments through which to determine optimal modes and sites of stimulus delivery, baseline assessments from which to tailor stimulation parameters, and less invasive tests that predict clinical outcome with GES are still awaited. This chapter explores what temporary and permanent GES can now achieve, as well as forthcoming developments in GES electrodes, devices, and anatomical mapping and placement.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
